CN104435072A - 一种具有辅助降血糖、降血脂的提取物及其制备方法 - Google Patents
一种具有辅助降血糖、降血脂的提取物及其制备方法 Download PDFInfo
- Publication number
- CN104435072A CN104435072A CN201410747586.8A CN201410747586A CN104435072A CN 104435072 A CN104435072 A CN 104435072A CN 201410747586 A CN201410747586 A CN 201410747586A CN 104435072 A CN104435072 A CN 104435072A
- Authority
- CN
- China
- Prior art keywords
- extract
- tea
- water
- francolin tea
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 23
- 239000008280 blood Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 10
- 239000008103 glucose Substances 0.000 title abstract description 10
- 230000000694 effects Effects 0.000 title abstract description 6
- 230000009467 reduction Effects 0.000 title abstract 4
- 235000013616 tea Nutrition 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 235000009508 confectionery Nutrition 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 5
- 239000011347 resin Substances 0.000 claims abstract description 5
- 229920005989 resin Polymers 0.000 claims abstract description 5
- 235000013361 beverage Nutrition 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract description 3
- 244000269722 Thea sinensis Species 0.000 claims description 33
- 241001165859 Perdicinae Species 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 125000003158 alcohol group Chemical group 0.000 claims description 12
- 230000003345 hyperglycaemic effect Effects 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 5
- 230000000055 hyoplipidemic effect Effects 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 3
- 239000003463 adsorbent Substances 0.000 claims description 3
- 201000001421 hyperglycemia Diseases 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007605 air drying Methods 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 238000011084 recovery Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000007902 hard capsule Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 235000015091 medicinal tea Nutrition 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 241000699670 Mus sp. Species 0.000 abstract description 19
- 238000002474 experimental method Methods 0.000 abstract description 5
- 238000010828 elution Methods 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 3
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 238000001179 sorption measurement Methods 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 abstract 3
- 241000288049 Perdix perdix Species 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 235000015092 herbal tea Nutrition 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 239000003480 eluent Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 4
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 229930184510 Mallotus Natural products 0.000 description 3
- 241001060384 Mallotus <angiosperm> Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 229960001052 streptozocin Drugs 0.000 description 3
- 241000221017 Euphorbiaceae Species 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- 230000002402 anti-lipaemic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920003266 Leaf® Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000013118 diabetic mouse model Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013360 fish flour Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- PMRYVIKBURPHAH-UHFFFAOYSA-N methimazole Chemical compound CN1C=CNC1=S PMRYVIKBURPHAH-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960002178 thiamazole Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410747586.8A CN104435072B (zh) | 2014-12-10 | 2014-12-10 | 一种具有辅助降血糖、降血脂的提取物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410747586.8A CN104435072B (zh) | 2014-12-10 | 2014-12-10 | 一种具有辅助降血糖、降血脂的提取物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104435072A true CN104435072A (zh) | 2015-03-25 |
CN104435072B CN104435072B (zh) | 2018-04-13 |
Family
ID=52882334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410747586.8A Active CN104435072B (zh) | 2014-12-10 | 2014-12-10 | 一种具有辅助降血糖、降血脂的提取物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104435072B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113925120A (zh) * | 2021-10-29 | 2022-01-14 | 海南振业英涛科技集团有限公司 | 一种针叶樱桃透明质酸钠复方饮品及其制备方法 |
CN115192651A (zh) * | 2022-05-12 | 2022-10-18 | 海南医学院 | 一种用于高血脂症的黎药组合物、黎药制剂及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1823796A (zh) * | 2005-12-24 | 2006-08-30 | 海南医学院 | 海南山苦茶木脂素和鞣质的医药用途及其制备方法 |
CN101336664A (zh) * | 2008-08-08 | 2009-01-07 | 海南省兴隆华侨农场咖啡厂 | 益智鹧鸪茶 |
CN102613355A (zh) * | 2012-03-02 | 2012-08-01 | 郝丹 | 鹧鸪茶液体饮料 |
-
2014
- 2014-12-10 CN CN201410747586.8A patent/CN104435072B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1823796A (zh) * | 2005-12-24 | 2006-08-30 | 海南医学院 | 海南山苦茶木脂素和鞣质的医药用途及其制备方法 |
CN101336664A (zh) * | 2008-08-08 | 2009-01-07 | 海南省兴隆华侨农场咖啡厂 | 益智鹧鸪茶 |
CN102613355A (zh) * | 2012-03-02 | 2012-08-01 | 郝丹 | 鹧鸪茶液体饮料 |
Non-Patent Citations (4)
Title |
---|
刘月丽等: ""山苦茶提取物对动脉粥样硬化大鼠血管内皮功能的影响"", 《中国热带医学》 * |
王志艳: "《华夏文明纵览》", 31 July 2006 * |
郭玲等: ""海南山苦茶中游离氨基酸的分析"", 《中国野生植物资源》 * |
闫佳等: ""山苦茶抗氧化功能研究"", 《农产品加工•学刊》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113925120A (zh) * | 2021-10-29 | 2022-01-14 | 海南振业英涛科技集团有限公司 | 一种针叶樱桃透明质酸钠复方饮品及其制备方法 |
CN113925120B (zh) * | 2021-10-29 | 2024-02-02 | 海南振业英涛科技集团有限公司 | 一种针叶樱桃透明质酸钠复方饮品及其制备方法 |
CN115192651A (zh) * | 2022-05-12 | 2022-10-18 | 海南医学院 | 一种用于高血脂症的黎药组合物、黎药制剂及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104435072B (zh) | 2018-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101292742A (zh) | 一种增强人体免疫功能的保健食品及其制备工艺 | |
CN101961061B (zh) | 一种普洱茶提取物及制备方法和应用 | |
CN109645200A (zh) | 一种玛咖压片糖果及其制备方法 | |
CN106729092A (zh) | 一种含低聚木糖的降血脂制剂及其制备方法和应用 | |
CN107753547A (zh) | 改善肠道菌群的皂苷类化合物、制备方法及其应用 | |
CN105832794A (zh) | 平卧菊三七在制备防治高尿酸血症药物、保健食品或功能食品中的应用 | |
CN106723015A (zh) | 一种具有抗疲劳和抗氧化功能的保健食品及其制备工艺 | |
CN105341893A (zh) | 一种辅助降血糖的组合物及应用 | |
CN105338993A (zh) | 含复合提取物的用于预防、改善或治疗大肠炎的组合物 | |
CN104523742B (zh) | 一种具有护肝和提高免疫作用的多糖组合物及其应用 | |
CN104435072A (zh) | 一种具有辅助降血糖、降血脂的提取物及其制备方法 | |
CN104055947A (zh) | 一种含有葡萄提取物的中药组合物及制备方法 | |
CN102764294A (zh) | 一种祛痰止咳组合物及其制备方法 | |
CN103920140B (zh) | 一种人用降糖减肥降脂复方制剂 | |
CN102614243B (zh) | 山茱萸总苷的提取方法及其在制备耐缺氧药物中的应用 | |
CN104286844A (zh) | 一种提高免疫力的食品、保健品或药物组合物 | |
CN106995772A (zh) | 一种增强免疫力的保健酒 | |
CN104055969B (zh) | 一种具有减肥作用的药物组合物 | |
CN105998196A (zh) | 一种含绞股蓝的降血糖保健药物组合物 | |
CN105360787A (zh) | 一种保健食品及其制备方法 | |
CN105770098A (zh) | 一种具有降血压的组合物及应用 | |
CN104273527B (zh) | 一种保健组合物及其制备方法和用途 | |
CN104524180A (zh) | 一种玛咖复方片及其制备方法与应用 | |
CN110559384A (zh) | 中药益生元组合物及其制备方法和应用 | |
CN103880913A (zh) | 一种具有保肝作用的化合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210324 Address after: 101407 Building 2, No. 36, Paradise Street, Yanqi Economic Development Zone, Huairou District, Beijing Patentee after: Beijing Huapeng Biotechnology Co.,Ltd. Address before: 571533 Hainan Branch, Institute of medicinal plants, Xinglong Town, Wanning City, Hainan Province Patentee before: INSTITUTE OF MEDICINAL PLANT DEVELOPMENT, CHINESE ACADEMY OF MEDICAL SCIENCES, HAINAN BRANCH. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Room 1901, Building 1, Xiexin Center, No. 19 Qinling Road, Laoshan District, Qingdao City, Shandong Province, 266100 Patentee after: Huaxi Biotechnology (Qingdao) Co.,Ltd. Country or region after: China Address before: 101407 Building 2, No. 36, Paradise Street, Yanqi Economic Development Zone, Huairou District, Beijing Patentee before: Beijing Huapeng Biotechnology Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |